# POLAR BEAR (NCT04332822)

> A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma

No report yet. It can be ordered.

- Drugs tested: R-pola-mini-CHP
- Indication: diffuse large B-cell lymphoma, ≥80 or frail ≥75

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04332822
- Phase: PHASE3
- Status: RECRUITING
- Sponsor: Nordic Lymphoma Group
- Conditions: DLBCL; Diffuse Large B Cell Lymphoma
- Interventions: R-pola-mini-CHP; R-mini-CHOP
- Enrollment: 300
- Primary outcome: Progression-free survival (PFS).

## Indexed commentary on POLAR BEAR so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- YouTube: 11
- X threads: 7
- Podcasts: 5
- X videos: 1

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=polar-bear-nct04332822

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04332822", "email": "<work email>"}; the inbox owner confirms by the emailed link.